Dr. Martens plc (LON:DOCS – Get Free Report) insider Kenny Wilson bought 199 shares of the business’s stock in a transaction on Wednesday, December 11th. The shares were acquired at an average price of GBX 76 ($0.96) per share, for a total transaction of £151.24 ($190.96).
Kenny Wilson also recently made the following trade(s):
- On Thursday, September 26th, Kenny Wilson purchased 30,000 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 55 ($0.69) per share, with a total value of £16,500 ($20,833.33).
Dr. Martens Trading Down 0.6 %
Shares of LON DOCS opened at GBX 76.55 ($0.97) on Monday. The company’s 50 day simple moving average is GBX 59.81 and its 200 day simple moving average is GBX 67.25. The company has a debt-to-equity ratio of 129.55, a current ratio of 2.85 and a quick ratio of 1.13. Dr. Martens plc has a fifty-two week low of GBX 49.32 ($0.62) and a fifty-two week high of GBX 100 ($1.26). The firm has a market capitalization of £736.20 million, a P/E ratio of 1,093.57, a P/E/G ratio of 6.40 and a beta of 0.11.
Dr. Martens Cuts Dividend
About Dr. Martens
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than Dr. Martens
- Why Invest in High-Yield Dividend Stocks?
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Canada Bond Market Holiday: How to Invest and Trade
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Most Effectively Use the MarketBeat Earnings Screener
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.